CellaVision appoints Acting CFO
(Thomson Reuters ONE) -
Sven-Åke Henningsson, member of CellaVision Board since 2006 and Chairman of the
Audit Committee, has been appointed Acting CFO from September 1 until a
permanent successor has been appointed.
CellaVision's Chief Financial Officer since 2007, Johan Wennerholm, will resign
at the end of September for new challenges outside the group. The process of
recruiting a new CFO has begun.
"I am very pleased and grateful that Sven-Åke has agreed to take the position as
Acting CFO. Sven-Åke has very good insight into CellaVision and with his deep
experience and expertise this is a perfect solution until we found a successor
to John Wennerholm", says Yvonne Mårtensson, CEO of CellaVision. "Johan has done
a fantastic job during his years at CellaVision, including being a driving force
in the process of listing CellaVision on Nasdaq OMX Small Cap in 2010. He has
been very important for the company's development and has contributed to
improvements in areas throughout our organization. I wish him all the best in
his new challenges."
Sven-Åke Henningsson is former CEO of Kanthal-Höganäs, AB Wilh Becker and
Lindéngruppen AB, and has held the position as CFO in several companies. He
serves on the board for Rittal Scandinavian AB and Gant Company AB among others.
Sven-Åke Henningsson will temporarily be replaced by board member Anna Malm
Bernsten in CellaVision's Audit Committee. Lars Henriksson, member of the board,
takes a temporary position as chairman of the committee.
For further information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82. Email: yvonne.martensson(at)cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge expertise
in image analysis, artificial intelligence and automated microscopy. In 2011
sales were SEK 155 million and sales continue to increase, with a growth target
of at least 15 % per year over an economic cycle. CellaVision's registered
office is in Lund and the company has subsidiaries in the USA, Canada and Japan.
The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at
www.cellavision.com.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1623886]
Unternehmensinformation / Kurzprofil:
Datum: 04.07.2012 - 09:08 Uhr
Sprache: Deutsch
News-ID 162352
Anzahl Zeichen: 3420
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision appoints Acting CFO"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
